Strs Ohio Boosts Holdings in National Health Investors, Inc. $NHI

Strs Ohio raised its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 293.6% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 167,300 shares of the real estate investment trust’s stock after buying an additional 124,800 shares during the period. Strs Ohio owned about 0.35% of National Health Investors worth $13,300,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the stock. EverSource Wealth Advisors LLC grew its holdings in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares during the period. Assetmark Inc. boosted its position in National Health Investors by 19.0% in the 2nd quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock worth $65,000 after purchasing an additional 148 shares in the last quarter. Farther Finance Advisors LLC grew its stake in shares of National Health Investors by 24.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,128 shares of the real estate investment trust’s stock worth $90,000 after purchasing an additional 225 shares during the period. NewEdge Advisors LLC increased its holdings in shares of National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares in the last quarter. Finally, Osaic Holdings Inc. lifted its stake in shares of National Health Investors by 24.1% in the 2nd quarter. Osaic Holdings Inc. now owns 1,629 shares of the real estate investment trust’s stock valued at $115,000 after purchasing an additional 316 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Performance

NYSE NHI opened at $79.47 on Monday. The company has a market cap of $3.79 billion, a PE ratio of 25.07, a price-to-earnings-growth ratio of 2.72 and a beta of 0.67. The stock’s 50 day simple moving average is $78.11 and its 200-day simple moving average is $76.37. National Health Investors, Inc. has a 1-year low of $65.22 and a 1-year high of $81.48. The company has a debt-to-equity ratio of 0.74, a current ratio of 10.64 and a quick ratio of 10.64.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, topping the consensus estimate of $1.24 by $0.08. The firm had revenue of $83.36 million during the quarter, compared to analysts’ expectations of $85.66 million. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The firm’s revenue for the quarter was down 1.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.03 earnings per share. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, equities research analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. National Health Investors’s payout ratio is presently 116.09%.

Wall Street Analysts Forecast Growth

NHI has been the topic of several analyst reports. Wells Fargo & Company raised their price target on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. Deutsche Bank Aktiengesellschaft cut National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price on the stock. in a research report on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 price target on National Health Investors in a report on Monday, January 5th. Truist Financial increased their price target on National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research report on Monday, December 15th. Finally, National Bankshares set a $85.00 price objective on National Health Investors in a report on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, National Health Investors presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.57.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.